These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18157162)

  • 1. Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells.
    Malfitano AM; Laezza C; Pisanti S; Gazzerro P; Bifulco M
    Br J Pharmacol; 2008 Mar; 153(5):1003-10. PubMed ID: 18157162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice.
    Malfitano AM; Laezza C; Galgani M; Matarese G; D'Alessandro A; Gazzerro P; Bifulco M
    Pharmacol Res; 2012 Mar; 65(3):365-71. PubMed ID: 22123497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism.
    Sarnataro D; Pisanti S; Santoro A; Gazzerro P; Malfitano AM; Laezza C; Bifulco M
    Mol Pharmacol; 2006 Oct; 70(4):1298-306. PubMed ID: 16822929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice.
    Malfitano AM; Sosa S; Laezza C; De Bortoli M; Tubaro A; Bifulco M
    Br J Pharmacol; 2011 Jan; 162(1):84-93. PubMed ID: 20880029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rimonabant inhibits proliferation, collagen secretion and induces apoptosis in hepatic stellate cells.
    Dai E; Zhang J; Zhang D; Yang L; Wang Y; Jiang X; Ye L; Li X; Liu H; Ma J; Jiang H
    Hepatogastroenterology; 2014 Oct; 61(135):2052-61. PubMed ID: 25713910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rimonabant (SR141716) induces metabolism and acquisition of fertilizing ability in human sperm.
    Aquila S; Guido C; Santoro A; Gazzerro P; Laezza C; Baffa MF; Andò S; Bifulco M
    Br J Pharmacol; 2010 Feb; 159(4):831-41. PubMed ID: 20067470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin.
    Gazzerro P; Malfitano AM; Proto MC; Santoro A; Pisanti S; Caruso MG; Notarnicola M; Messa C; Laezza C; Misso G; Caraglia M; Bifulco M
    Oncol Rep; 2010 Jan; 23(1):171-5. PubMed ID: 19956878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human sperm anatomy: ultrastructural localization of the cannabinoid1 receptor and a potential role of anandamide in sperm survival and acrosome reaction.
    Aquila S; Guido C; Santoro A; Perrotta I; Laezza C; Bifulco M; Sebastiano A
    Anat Rec (Hoboken); 2010 Feb; 293(2):298-309. PubMed ID: 19938110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CB1 endocannabinoid system modulates adipocyte insulin sensitivity.
    Motaghedi R; McGraw TE
    Obesity (Silver Spring); 2008 Aug; 16(8):1727-34. PubMed ID: 18551116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential antipsychotic properties of central cannabinoid (CB1) receptor antagonists.
    Roser P; Vollenweider FX; Kawohl W
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):208-19. PubMed ID: 20218784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes.
    Gary-Bobo M; Elachouri G; Scatton B; Le Fur G; Oury-Donat F; Bensaid M
    Mol Pharmacol; 2006 Feb; 69(2):471-8. PubMed ID: 16282221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-lipoxygenase mediates docosahexaenoyl ethanolamide and N-arachidonoyl-L-alanine-induced reactive oxygen species production and inhibition of proliferation of head and neck squamous cell carcinoma cells.
    Park SW; Hah JH; Oh SM; Jeong WJ; Sung MW
    BMC Cancer; 2016 Jul; 16():458. PubMed ID: 27411387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells.
    Ciaglia E; Torelli G; Pisanti S; Picardi P; D'Alessandro A; Laezza C; Malfitano AM; Fiore D; Pagano Zottola AC; Proto MC; Catapano G; Gazzerro P; Bifulco M
    Oncotarget; 2015 Jun; 6(17):15464-81. PubMed ID: 26008966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anandamide inhibits adhesion and migration of breast cancer cells.
    Grimaldi C; Pisanti S; Laezza C; Malfitano AM; Santoro A; Vitale M; Caruso MG; Notarnicola M; Iacuzzo I; Portella G; Di Marzo V; Bifulco M
    Exp Cell Res; 2006 Feb; 312(4):363-73. PubMed ID: 16343481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of peripheral hepatic cannabinoid receptor-1 improves liver lipid metabolism in mice: evidence from cultured explants.
    Jourdan T; Demizieux L; Gresti J; Djaouti L; Gaba L; Vergès B; Degrace P
    Hepatology; 2012 Mar; 55(3):790-9. PubMed ID: 21987372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth.
    Bifulco M; Laezza C; Portella G; Vitale M; Orlando P; De Petrocellis L; Di Marzo V
    FASEB J; 2001 Dec; 15(14):2745-7. PubMed ID: 11687506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rimonabant-induced apoptosis in leukemia cell lines: activation of caspase-dependent and -independent pathways.
    Gallotta D; Nigro P; Cotugno R; Gazzerro P; Bifulco M; Belisario MA
    Biochem Pharmacol; 2010 Aug; 80(3):370-80. PubMed ID: 20417624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.
    Duarte C; Alonso R; Bichet N; Cohen C; Soubrié P; Thiébot MH
    Neuropsychopharmacology; 2004 May; 29(5):911-20. PubMed ID: 14694354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the cannabinoid antagonist SR141716 (rimonabant) and d-amphetamine on palatable food and food pellet intake in non-human primates.
    Foltin RW; Haney M
    Pharmacol Biochem Behav; 2007 Apr; 86(4):766-73. PubMed ID: 17445873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of AM1346, a high-affinity CB1 receptor selective anandamide analog, on open-field behavior in rats.
    Järbe TU; DiPatrizio NV; Li C; Makriyannis A
    Behav Pharmacol; 2007 Nov; 18(7):673-80. PubMed ID: 17912052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.